Aakash Shah is the founder and CEO of Wyndly, a telehealth company specializing in allergy immunotherapy. In this conversation, we explore Wyndly’s mission to make allergy treatment more accessible and personalized. Key topics include the evolution from traditional allergy treatments to innovative at-home diagnostics, the impact of AI in customer support, and the challenges of fostering a strong corporate culture in a fast-growing startup.

EPISODE LINKS:

• Aakash Shah's LinkedIn: https://www.linkedin.com/in/mraakashshah/
• Wyndly Website: https://www.wyndly.com/

TIMESTAMPS:

00:00:12 Introduction and background 00:01:24 Traditional Allergy Treatments vs Innovative At-Home Allergy Solutions 00:05:37 US Healthcare System 00:07:41 Startups in the Medical Space 00:10:04 Starting a Medical Services Company 00:15:06 Y Combinator Program 00:17:46 Maintaining Fast-Paced Growth 00:20:19 Compounding Learning 00:21:09 Building a Fast-Moving Culture 00:26:14 AI 00:37:07 Windly's Vision and Future 00:38:08 Closing

CONNECT:

• Website: https://hoo.be/elijahmurray
• YouTube: https://www.youtube.com/@elijahmurray
• Twitter: https://twitter.com/elijahmurray
• Instagram: https://www.instagram.com/elijahmurray
• LinkedIn: https://www.linkedin.com/in/elijahmurray/
• Apple Podcasts: https://podcasts.apple.com/us/podcast/the-long-game-w-elijah-murray/
• Spotify: https://podcasters.spotify.com/pod/show/elijahmurray
• RSS: https://anchor.fm/s/3e31c0c/podcast/rss